Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Nab-paclitaxel
Interventions: DRUG: Nab-paclitaxel + Carboplatin|DRUG: Nab-paclitaxel + Capecitabine
Sponsor: Hebei Medical University Fourth Hospital
Collaborators: Beijing 302 Hospital|CSPC Ouyi Pharmaceutical Co., Ltd.